Impact of Contraceptives on Cervico-Vaginal Mucosa
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
UMPALA is a research study to look at the effect of four different, approved contraceptives
on the cervical and vaginal tissues as well as on factors in the blood. Participants will
have a baseline examination then receive one of four approved, marketed contraceptive
products. Cervico-vaginal assessments will take place 4 weeks after contraceptive initiation
and 3 months after to assess changes in mucosal safety after use of various contraceptive
products in young, healthy, HIV uninfected women.
Phase:
Phase 4
Details
Lead Sponsor:
Eastern Virginia Medical School
Collaborators:
CONRAD Kenya Medical Research Institute United States Agency for International Development (USAID)